PILA — Pila Pharma AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK71.16m
- SEK70.08m
- SEK0.77m
Annual balance sheet for Pila Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.91 | 28.2 | 7.24 | 5.95 | 4.89 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.049 | 0.149 | 0.203 | 0.276 | 0.073 |
| Prepaid Expenses | |||||
| Total Current Assets | 2.03 | 28.5 | 7.59 | 6.24 | 5.01 |
| Net Property, Plant And Equipment | 0.036 | 0.016 | 0 | 0 | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 5.37 | 31.8 | 10.9 | 8.46 | 6.22 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.95 | 1.51 | 1.36 | 1.79 | 0.962 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.95 | 1.51 | 1.36 | 1.79 | 0.962 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3.42 | 30.3 | 9.53 | 6.66 | 5.26 |
| Total Liabilities & Shareholders' Equity | 5.37 | 31.8 | 10.9 | 8.46 | 6.22 |
| Total Common Shares Outstanding |